Sign up and be the first to get updates on MG information that matters to you!

I authorize argenx US, Inc. ("argenx"), its affiliates and companies working with argenx to use my contact information and health information (“Information”) to contact me by direct mail, email, telephone and autodialed text message for marketing purposes, such as to provide me with information, offers and promotions regarding myasthenia gravis, argenx products and programs, to conduct market research or surveys, and to use my Information to develop future products, services and programs.

I understand that I may withdraw my authorization provided above by emailing [email protected] or following the unsubscribe instructions on the communication. Unless I withdraw this authorization, it will remain effective for 2 years. Copies of this authorization may be obtained by emailing [email protected]